APA (7th ed.) Citation

N, D., NJ, S., X, Z., H, J., C, P., Y, W., . . . Y, Y. (2024). Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. Blood advances, 8(12), 3140. https://doi.org/10.1182/bloodadvances.2023012073

Chicago Style (17th ed.) Citation

N, Denlinger, et al. "Postinfusion PD-1+ CD8+ CAR T Cells Identify Patients Responsive to CD19 CAR T-cell Therapy in Non-Hodgkin Lymphoma." Blood Advances 8, no. 12 (2024): 3140. https://doi.org/10.1182/bloodadvances.2023012073.

MLA (9th ed.) Citation

N, Denlinger, et al. "Postinfusion PD-1+ CD8+ CAR T Cells Identify Patients Responsive to CD19 CAR T-cell Therapy in Non-Hodgkin Lymphoma." Blood Advances, vol. 8, no. 12, 2024, p. 3140, https://doi.org/10.1182/bloodadvances.2023012073.